What is an Institutional Review Board?

by | Feb 3, 2020 | FDA, Gene and Cell Therapies, Medical Devices

An institutional review board, or IRB, is a group of experts who are appointed to monitor and review biomedical research involving human subjects at a facility. An IRB plays an important role for medical device manufacturers as they will oversee any clinical research activities in order to protect the rights of the human research subjects. In order to conduct a clinical trial on your medical device, you will have to submit and be approved by an IRB.1

Before you can begin your clinical trial, you will have to prepare and submit a packet to the IRB consisting of the following:

  1. The research protocol
  2. Informed consent forms
  3. Recruiting materials that were used to recruit participants
  4. The Principal Investigator’s (PI) CV.

Depending on the IRB you are submitting to you may also have to submit additional information such as a detailed device description and information on available resources for the study. The IRB will review all submitted information and assess the ethicality of the research which includes ensuring the methods used during the study are designed to minimize patient risk and making sure all subjects fully understand the study prior to participating. IRBs also assess whether the proposed Principle Investigator (PI) is qualified to manage the research.2

Once submitted to an IRB, the review process can follow one of two paths: a full board review or an expedited review. An expedited review usually only takes a couple of days and can be completed by one appointed person on the IRB. A full board review is required if one of the following is true: test participants include minors, have pre-existing medical conditions such as Cystic Fibrosis, or the device requires an Investigational Device Exemption Application. If none of these are true, then the submission is generally eligible for an expedited IRB review.3

Once the IRB approves a submission and the clinical trial starts, the board stays involved by performing continuing reviews of all study-related materials at least once a year. The IRB also reviews all material at the conclusion of a clinical trial.4

IRBs are critical to medical device studies as they ensure the safety of the subjects and regulate the ethicality of the clinical trial. EMMA International can help you prepare for an IRB review and support you through a clinical trial. Call us at 248-987-4497 or email info@emmainternational.com to see how we can help!


1FDA (September 2018) IDE Institutional Review Boards (IRB) retrieved on 01/29/2020 from: https://www.fda.gov/medical-devices/investigational-device-exemption-ide/ide-institutional-review-boards-irb

2WHO (2002) Handbook for Good Clinical Research Practice (GCP) retrieved on 01/29/2020 from: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/gcp1.pdf

3Johns Hopkins Office of Human Subjects Research (April 2016) Expedited Review Process retrieved on 01/30/2020 from: https://www.hopkinsmedicine.org/institutional_review_board/guidelines_policies/guidelines/expedited_review.html

4PPD (n.d.) IRB/EC in Clinical Trials retrieved on 01/30/2020 from: https://www.ppdi.com/participate-in-clinical-trials/become-an-investigator/institutional-review-board

Madison Wheeler

Madison Wheeler

Director of Technical Operations - Ms. Wheeler serves as EMMA International’s Director of Technical Operations. She has experience in technical writing, nonconforming product management, issue evaluations, and implementing corrective and preventative actions in the pharmaceuticals and medical device industries. She has experience cross-functionally between R&D, lean manufacturing operations, and RA compliance. Ms. Wheeler also has academic and work experience with human health-risk engineering controls, physiological biophysics, and clinical research. Ms. Wheeler holds a Bachelor of Science in Biosystems Engineering with a concentration in Biomedical Engineering from Michigan State University. She is also a Certified Quality Auditor (CQA), and is currently pursuing her M.S. in Quality Management.

More Resources

De Novo Classification

De Novo Classification

A device can be registered for the De Novo pathway if there is evidence of the safety and effectiveness of the device and there is not a previously legally marketed predicate device1. When determining if your device can go through the De Novo process there are two pathways available to determine the device classification.
Abbreviated 510k submission

Abbreviated 510k submission

There are three types of 510K, Premarket Notifications, which can be submitted to the Food and Drug Administration (FDA) traditional, abbreviated, and special. Abbreviated and Special 510K submissions can be utilized when the submissions meet the certain factors presented by the FDA. When submitting an abbreviated 510K the submission must include the elements that are identified in 21CFR 807.87 for the information required in a premarket notification submission.
Is your product a medical device?

Is your product a medical device?

Many marketed products are classified as medical devices and you would not even know it. Medical devices range from latex gloves and tongue depressors to respirators and heart valves. To determine if the product is considered a medical device by the Food and Drug Administration (FDA) you will need to analyze if your product meets the definition of a medical device per the Food, Drug, and Cosmetic Act1.

Ready to learn more about working with us?

Pin It on Pinterest

Share This